Adding Atezolizumab to mFOLFOX6 Improves DFS Among Patients with Stage III dMMR Colon Cancer By Ogkologos - March 31, 2026 4 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ATOMIC study Source RELATED ARTICLESMORE FROM AUTHOR Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Tarlatamab Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer MOST POPULAR Study Finds the Cost of Treating Metastatic Breast Cancer Could More... August 3, 2021 Female Representation at the Top of the Oncology Field Has Hit... October 20, 2021 New Technology System Allows Patients To Get A Mammogram And Biopsy... June 30, 2020 Bowel Cancer Data Reinforce Need to Reduce Unnecessary Antibiotic Use [ESMO... July 2, 2021 Load more HOT NEWS Young Mom Battles Breast Cancer After Being Misdiagnosed with a Blocked... Foodie Fridays: Farmer’s Market Finds Adjuvant Chemotherapy Customisation Based on ERCC1 and TS mRNA Levels Does... New on NCI’s Websites for December 2022
